In 1983 we reported the preliminary findings in an epidemiological study of 247 women with primary breast cancer and a like number of matched control women, all ofwhom were under 45 years ofage.' There was a strong association between use of oral contraceptives before first term pregnancy and risk of breast cancer (relative risk for one to 12 months' use, 1 2; for 13-48 months' use, 1-7; for 49 or more months' use, 3-1). More recently, the final results of this study were published based on 351 case-control pairs aged under 45 years.2 The findings previously reported on oral contraceptive use before first term pregnancy were replicated but no overall association was found between use of oral contraceptives and risk of breast cancer.
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Shortly after the publication of our preliminary report we decided to undertake a histopathological review of as many as possible of the neoplasms in the 261 women with primary breast cancer who had by then been included in the study. We judged this to be important because the study had produced worrying findings and we considered that histopathological data might help in the interpretation of the association between early use of oral contraceptives and breast cancer.
Subjects and methods
The 261 women with breast cancer were all married Accepted for publication 16 November 1988 but otherwise formed a consecutive series identified at eight hospitals in London and Oxford between 1980 and 1983. Each woman had been interviewed by a research nurse who had obtained a comprehensive history including details of oral contraceptive use. We attempted to recover histological material from the primary tumour for each woman, but failed to obtain cooperation at one hospital where 19 women had been treated, thus reducing the sample to 242. Of these, no histological material could be obtained from the primary tumour for 12, while four had had only a Trucut biopsy specimen taken, which enabled us to confirm the diagnosis of malignancy but did not permit detailed histological evaluation. Three biopsy specimens showed no conclusive evidence of malignancy, another included insufficient material for assessment, while one woman had an angiosarcoma of the breast. Four women had multiple primary carcinomas with a total of 10 tumours between them. Accordingly, some degree of assessment was possible for 227 carcinomas in 221 women. The amount of material available for review varied widely from case to case, but in all at least one representative section of the tumour was examined. The assessment of the material was undertaken by one of us (NM) Miller, McPherson, Jones, Vessey contraceptives were, of course, younger on average than non-users. Accordingly, all the percentages shown in the tables are adjusted for age, using direct standardisation and grouping of the women in the three age categories defined above.
Results
The results of the histopathological review of the 227 tumours are given in tables 1-4. We decided that it would be simpler and more informative to base the results on tumours rather than on women, although the difference between the two approaches is obviously very minor. Table I shows that the carcinomas occurring in pill users were a little less often of the infiltrating ductal NOS type than those occurring in non-users; conversely, tumours of other types were relatively more common in pill users than in non-users. In particular, six of seven in situ ductal cancers (86%) and 14 of 19 infiltrating lobular cancers (74%) occurred among the 145 (64%) of women who had at some time used oral contraceptives. The distributions of the different histological types of cancer did not vary significantly, however, when pill users and non-users were compared (this was true both for pill use at any time and for use before first term pregnancy).
The crude data on histological grade of tumour suggested a more unfavourable distribution among pill users than among non-users. Adjustment of the figures for the effect of age, however, yielded the unremarkable percentages shown in table 2.
Again, although the data on other tumour characteristics given in table 3 show considerable variation, no clear patterns are apparent and there are no significant trends in relation to use of oral contraceptives, either at any time or before first term pregnancy. group The data set which is the subject ofthis paper is one of those which has produced worrying findings, and for this reason we thought that a histopathological review of the cancers would be especially worthwhile.
Similar reviews seem to be sparse, and those that do exist have generally been conducted in a more restricted way than the present one. Penman reported on a single case of breast cancer occurring in a 27 year old woman using the pill." He noted prominent "colostrum corpuscles" in the intraduct element of the tumour and found the lymph node metastases to be composed of strikingly eosinophilic cells. He thought these "peculiar histological features" might be related to use of the pill. Fechner'2 described a series of five breast cancers occurring in pill users under 35 years of age and noted no special features. Gould et al reported on another small series of cases in pill users (aged 24, 29, and 46) and found that all "had both lobular and ductal components, secretory activity and conspicuous mucopolysaccharides in the stroma".'3 In addition, "the lesions were pleomorphic and diffuse and contained abundant lymphocytic infiltration". A larger study was reported later by Vessey et al '4 of 31 breast cancers in pill users and 59 in non-users (all aged under 40 years). No points of distinction were found between the lesions from patients who had used oral contraceptives and those from patients who had not. A similar conclusion was reached in a review of the literature by Fechner'5 and in a study of 77 cancers in pill users and 58 in non-users reported by the Royal College of General Practitioners.'6 Matthews et al, however, found a series of 93 tumours occurring in pill users to be significantly better differentiated on average than a series of 93 tumours occurring in non-users." The two groups of women studied were matched for age and parity.
Our results must be added to those which are essentially negative although the (necessarily) small size of the sample studied makes it likely that only major differences between users and non-users of oral contraceptives would have been discernible. None the less we believe our study to be of special interest, not only because of the detailed way in which the review was conducted, but also because the material was derived from an epidemiological study which strongly suggested a positive association between early pill use and breast cancer.
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